{"data":{"id":"us-ky/krs-311.774","jurisdiction":"us-ky","citation":"KRS 311.774","heading":"Report on prescriptions for abortion-inducing drugs -- Information on","body":"potential reversal of effect of drugs to be included with prescription --\nComplications  and  adverse  events to be reported to Vital Statistics\nBranch.\n(1) Each  prescription issued for an abortion-inducing drug as defined in KRS\n311.7731 for which the primary indication is the induction of abortion as defined\nin KRS  311.720 shall be reported on a report form provided by the cabinet\nwithin three (3) days after the prescription was issued. The report form shall be\nsigned by the qualified physician who provided the abortion-inducing drug and\ntransmitted to the cabinet within three (3) days after the drug was provided.\nEach report shall include at minimum the information required by KRS 213.101.\n(2) Information on the potential ability of a physician to reverse the effects of\nabortion-inducing drugs as defined in KRS  311.7731 for which the primary\nindication is the induction of abortion, including where additional information\nabout this possibility may be obtained and contact information for assistance in\nlocating a physician who may aid in the reversal, shall be provided with each\nprescription issued for an  abortion-inducing drug for which the primary\nindication is the induction of abortion as defined in KRS 311.720.\n(3) For each abortion reported to the Vital Statistics Branch as required by KRS\n213.101, the report shall also state whether any abortion complication or\nadverse event as defined in KRS  311.7731 or medical treatment was known to\nthe provider as a result of the abortion. The report shall be completed and\nsigned by the physician, qualified physician, or other healthcare provider who\ndiagnosed or treated the complication or adverse event.\n(4) The  report shall include at a minimum  the information required by KRS\n213.101 and:\n(a) Whether  a complication or adverse event as defined in KRS  311.7731\noccurred during the abortion procedure or while the pregnant patient was\nstill at the facility where the abortion was performed and the level of\nintervention required to attend to the complication or adverse event:\n1. Emergency  medical services;\n2. Stabilization on site;\n3. Transport to another medical facility;\n4. Urgent care follow-up; and\n5. Primary care provider;\n(b) The date the pregnant patient presented for diagnosis or treatment for the\ncomplication or adverse event;\n(c) Whether the complication or adverse event was previously managed  by\nthe qualified physician who  provided the abortion-inducing drug as\ndefined in KRS 311.7731 or a backup qualified physician;\n(d) The  amount  billed to cover the treatment for specific complications,\nincluding whether the treatment was billed to Medicaid, private insurance,\nprivate pay, or other method. This should include the ICD-10 codes\nreported and charges for any physician, hospital, emergency  room,\nprescription or other drugs, laboratory tests, and any other costs for\ntreatment rendered; and\n(e) A list of complications, adverse events, or treatments that occurred, a list\nof any emergency  transfers, and  any follow-up treatment provided\nincluding whether any additional drugs were provided in order to complete\nthe drug-induced abortion.","path":["KRS Chapter 311"],"source_url":"https://apps.legislature.ky.gov/law/statutes/statute.aspx?id=52238","current_through":"Includes enactments through the 2026 Regular Session","vintage":"09/05/2026","retrieved_at":"2026-09-05T20:58:06Z","sha256":"4777c3feb0b09478a611eec5e1681770c1005f991b7f0c1d4103ab8ac09990cd","source_id":"us-ky","stale":false,"prev":"us-ky/krs-311.7739","next":"us-ky/krs-311.7741"},"notice":"GroundRules: Original legal text. Not legal advice."}